Skip to main content
Log in

Significant Genetic Linkage of MDR1 Polymorphisms at Positions 3435 and 2677: Functional Relevance to Pharmacokinetics of Digoxin

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. S. V. Ambudkar, S. Dey, C. A. Hrycyna, M. Ramachandra, I. Pastan, and M. M. Gottesman. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu.Rev.Pharmacol.Toxicol. 39:361-398 (1999).

    Google Scholar 

  2. F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham. Cellular localization of the multidrugresistance gene product P-glycoprotein in normal human tissues. Proc.Natl.Acad.Sci.USA 84:7735-7738 (1987).

    Google Scholar 

  3. N. Kioka, J. Tsubota, Y. Kakehi, T. Komano, M. M. Gottesman, I. Pastan, and K. Ueda. P-glycoprotein gene (MDR1) cDNA from human adrenal: Normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem.Biophys.Res.Commun. 162:224-231 (1989).

    Google Scholar 

  4. L. A. Mickley, J. S. Lee, Z. Weng, Z. Zhan, M. Alvarez, W. Wilson, S. E. Bates, and T. Fojo. Genetic polymorphism in MDR-1: A tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood 91:1749-1756 (1998).

    Google Scholar 

  5. S. Hoffmeyer, O. Burk, O. von Richter, H. P. Arnord, J. Brockmoller, A. Johne, I. Cascorbi, T. Gerloff, I. Roots, M. Eichelbaum, and U. Brinkmann. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc.Natl.Acad.Sci.USA 92:3473-3478 (2000).

    Google Scholar 

  6. S. Ito, I. Ieiri, M. Tanabe, A. Suzuki, S. Higuchi, and K. Otsubo. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics 11:175-184 (2001).

    Google Scholar 

  7. M. Tanabe, I. Ieiri, N. Nagata, K. Inoue, S. Ito, Y. Kanamori, M. Takahashi, Y. Kurata, J. Kigawa, S. Higuchi, N. Terakawa, and K. Otsubo. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J.Pharmacol.Exp.Ther. 297:1137-1143 (2001).

    Google Scholar 

  8. M. Hitzl, S. Drescher, H. van der Kuip, E. Schaffeler, J. Fischer, M. Schwab, M. Eichelbaum, and M. F. Fromm. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 11:293-298 (2001).

    Google Scholar 

  9. T. Nakamura, T. Sakaeda, M. Horinouchi, T. Tamura, N. Aoyama, T. Shirakawa, M. Matsuo, M. Kasuga, and K. Okumura. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on the MDR1-mRNA expression level in duodenal enterocytes of healthy Japanese subjects. Clin.Pharmacol.Ther. 71:297-303 (2002).

    Google Scholar 

  10. L. Becquemont, C. Verstuyft, R. Kerb, U. Brinkmann, M. Lebot, P. Jaillon, and C. Funck-Brentano. Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clin.Pharmacol.Ther. 70: 311-316 (2001).

    Google Scholar 

  11. T. Sakaeda, T. Nakamura, M. Horinouchi, M. Kakumoto, N. Ohmoto, T. Sakai, Y. Morita, T. Tamura, N. Aoyama, M. Hirai, M. Kasuga, and K. Okumura. MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm.Res. 18:1400-1404 (2001).

    Google Scholar 

  12. N. von Ahsen, M. Richter, C. Grupp, B. Ringe, M. Oellerich, and V. W. Armstrong. No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients. Clin.Chem. 47:1048-1052 (2001).

    Google Scholar 

  13. R. B. Kim, B. F. Leake, E. F. Choo, G. K. Dresser, S. V. Kubba, U. I. Schwarz, A. Taylor, H. G. Xie, J. McKinsey, S. Zhou, L. B. Lan, J. D. Schuetz, E. G. Schuetz, and G. R. Wilkinson. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin.Pharmacol.Ther. 70: 189-199 (2001).

    Google Scholar 

  14. I. Cascorbi, T. Gerloff, A. Johne, C. Meisel, S. Hoffmeyer, M. Schwab, E. Schaeffeler, M. Eichelbaum, U. Brinkmann, and I. Roots. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin.Pharmacol.Ther. 69:169-174 (2001).

    Google Scholar 

  15. M. M. Ameyaw, F. Regateiro, T. Li, X. Liu, M. Tariq, A. Mobarek, N. Thornton, G. O. Folayan, J. Githang'a, A. Indalo, D. Ofori-Adjei, D. A. Price-Evans, and H. L. McLeod. MDR1 pharmacogenetics: Frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 11:217-221 (2001).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katsuhiko Okumura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horinouchi, M., Sakaeda, T., Nakamura, T. et al. Significant Genetic Linkage of MDR1 Polymorphisms at Positions 3435 and 2677: Functional Relevance to Pharmacokinetics of Digoxin. Pharm Res 19, 1581–1585 (2002). https://doi.org/10.1023/A:1020433422259

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020433422259

Navigation